Meetings: Oversight of Laboratory Developed Tests
Document ID: FDA-2010-N-0274-0001
Comments
Total: 96
-
Timothy Paul Janzen - Comment
Posted : 08/17/2010 ID :FDA-2010-N-0274-0094 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
XDx (Expression Diagnostics) - Comment
Posted : 08/19/2010 ID :FDA-2010-N-0274-0096 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Abbott Molecular, Inc. - Comment
Posted : 08/23/2010 ID :FDA-2010-N-0274-0098 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Parent Heart Watch - Comment
Posted : 09/22/2010 ID :FDA-2010-N-0274-0100 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
QIAGEN - Comment
Posted : 10/22/2010 ID :FDA-2010-N-0274-0120 Agency : FDA -
Aug 15,2010 11:59 PM ET
-
Australian Government Department of Health and Ageing Therapeutic Goods Administration - Comment
Posted : 10/26/2010 ID :FDA-2010-N-0274-0121 Agency : FDA -
Aug 15,2010 11:59 PM ET